Phase 2 Trial to Assess EP-101 Cancer Vaccine-Bavencio Combo Therapy in HER2- Breast Cancer Patients
News
EpiThany says it will test its multi-antigen vaccine EP-101 STEMVAC — in combination with the PD-L1 antibody Bavencio (avelumab) — as a neoadjuvant therapy in breast cancer patients, under a three-way agreement ... Read more